MEDIA CONTACT: mediarelations@usp.org
Drug shortages pose a significant, ongoing threat to our healthcare system and to the patients who rely on medicine for their wellbeing and survival. The USP Medicine Supply Map shows that 125 drug products were in shortage at the end of 2023, the highest number in a decade. And shortages are lasting longer than ever, with a 3-year average duration in 2023 compared to 2 years in 2022.
Biologic medicines – “biologics” for short. You’ve probably seen commercials for some of them on TV. Maybe you or someone you know is even taking one. But what exactly are they? And what about “biosimilars”? You might also be wondering whether they’re safe and effective.
The rise of third-party online shopping platforms – think TikTok Shop, Amazon and sponsored content on Meta-owned platforms – has fostered a culture where consumers are comfortable trusting influencer recommendations, often purchasing items without critical examination of a product and its claims. For some products – like dietary supplements – an impulse buy can be dangerous.
The Medicine Maker | August 28, 2024
The New York Times | August 13, 2024
Find USP Comment Letters, White Papers, Sign-on Letters, Testimony, Issue Briefs and Policy Positions
